Announcements Trials

Browse Landscape

Status

Withdrawn 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 24 Breast Neoplasms 11 Prostatic Neoplasms 10 Colorectal Neoplasms 10 Hematologic Neoplasms 7 Ovarian Neoplasms 6 Lung Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Multiple Myeloma 4 Advanced Cancer 4 Uterine Cervical Neoplasms 3 Rectal Neoplasms 3 Lymphoma 3 Head and Neck Neoplasms 3 Gastrointestinal Neoplasms 3 Sarcoma 2 Peritoneal Neoplasms 2 Pain 2 Neoplasm Metastasis 2 Mouth Neoplasms 2 Melanoma 2 Low Anterior Resection Syndrome 2 Hematopoietic and Lymphoid System Neoplasm 2 Fatigue 2 Endometrial Neoplasms 2 Depression 2 Colorectal Neoplasms, Hereditary Nonpolyposis 2 Colonic Neoplasms 2 Brain Neoplasms 2 Bone Neoplasms 2

Interventions

Gemcitabine 27 Fluorouracil 25 Oxaliplatin 21 Cisplatin 19 Leucovorin 17 Bevacizumab 15 130-nm albumin-bound paclitaxel 13 Docetaxel 12 Capecitabine 12 Albumin-Bound Paclitaxel 12 Paclitaxel 11 Irinotecan 10 Carboplatin 9 pembrolizumab 7 Radiotherapy 6 Pemetrexed 6 Nivolumab 6 Erlotinib Hydrochloride 6 Cyclophosphamide 6 Trastuzumab 5 Ramucirumab 5 Ipilimumab 4 Everolimus 4 Crizotinib 4 Cetuximab 4 vandetanib 3 trastuzumab deruxtecan 3 sargramostim 3 folfirinox 3 Sorafenib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Adenocarcinoma × Interviews as Topic × Clear all

NCT03963739 2025-07-16

PCW

Wake Forest University Health Sciences

Adenocarcinoma, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡